Compare Organon Pharma Indonesia Tbk. (SCPI) vs Northcliff Citranusa Indonesia Tbk. (SKYB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon Pharma Indonesia Tbk. vs Northcliff Citranusa Indonesia Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Northcliff Citranusa Indonesia Tbk. trades at Rp51 (market cap 29.84B). The key difference: Organon Pharma Indonesia Tbk. is far larger — about 3.5× Northcliff Citranusa Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | SKYB | |
|---|---|---|
Market Cap | 104.4B | 29.84B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →About Northcliff Citranusa Indonesia Tbk.
PT Skybee (the company) was established under its original name of PT Kreatip Komunikacitra base on notarial deed No.12 of Lilianan Indrawati, S.H, dated on Jun 10, 1995. The Company’s articles of association has been amended several times, most recently by notarial deed No. 03 of Leolin J, S.H., dated Mar 12, 2010, concerning among others, the change in the Company’s name, and public offering.
Read more on SKYB →
